February 7, 2012 (Miami, Florida) — Corneal crosslinking is a procedure that is being used in other countries but has not yet been approved by the US Food and Drug Administration (FDA) in the United ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Please provide your email address to receive an email when new articles are posted on . Corneal transplantation for keratoconus has traditionally been performed as a full-thickness penetrating ...

Please provide your email address to receive an email when new articles are posted on . A new microwave procedure, Keraflex KXL from Avedro, holds the promise of ...

There is no cure for keratoconus, but the cornea can be strengthened to slow or halt the progression of the disease with an FDA-approved cross-linking procedure called iLink®. Once diagnosed, there is ...

Providence Health Plan, Health New England, and Public Employees Health Plan Are Latest to Join Extensive List of Payers Covering Over 95% of Estimated Total U.S. Addressable Market for Progressive ...

An innovative procedure may improve outcomes in people with a degenerative eye disease, suggest five-year results from a study presented at AAO 2016, the 120th annual meeting of the American Academy ...

For most of his young life, the 15-year-old Wyoming High School sophomore ran into things, struggled with activities he enjoyed like catching a baseball and even found himself missing the other hand ...

Pre-2000, the clinical management of keratoconus centred on rigid contact lens fitting when spectacle corrected acuity was no longer adequate, and transplantation where contact lens wear failed. Over ...

WALTHAM, Mass., April 05, 2019 (GLOBE NEWSWIRE) -- Avedro, Inc., (Avedro or the company), today announced that four new providers --Providence Health Plan in the Pacific Northwest, Health New England, ...